Literature DB >> 14985113

Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin.

Monika Kulartz1, Ekkehard Hiller, Ferdinand Kappes, Lorenzo A Pinna, Rolf Knippers.   

Abstract

Geminin contributes to cell cycle regulation by a timely inhibition of Cdt1p, the loading factor required for the assembly of pre-replication complexes. Geminin is expressed during S and G2 phase of the HeLa cell cycle and phosphorylated soon after its synthesis. We show here that Geminin is an excellent substrate for protein kinase CK2 in vitro; and that the highly specific CK2 inhibitor tetrabromobenzotriazole (TBB) blocks the phosphorylation of Geminin in HeLa protein extracts and HeLa cells in vivo. The sites of CK2 phosphorylation are located in the carboxyterminal region of Geminin, which carries several consensus sequence motifs for CK2. We also show that a minor phosphorylating activity in protein extracts can be attributed to glycogen synthase kinase 3 (GSK3), which most likely targets a central peptide in Geminin. Treatment of HeLa cells with TBB does not interfere with the ability of Geminin to interact with the loading factor Cdt1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985113     DOI: 10.1016/j.bbrc.2004.01.164

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein.

Authors:  David A Canton; Mary Ellen K Olsten; Kyoungtae Kim; Amanda Doherty-Kirby; Gilles Lajoie; John A Cooper; David W Litchfield
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

2.  Development and exploitation of CK2 inhibitors.

Authors:  Stefania Sarno; Maria Ruzzene; Pietrogiulio Frascella; Mario A Pagano; Flavio Meggio; Alfonso Zambon; Marco Mazzorana; Giovanni Di Maira; Vittorio Lucchini; Lorenzo A Pinna
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

3.  Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.

Authors:  Jinjin Zou; Hesan Luo; Qin Zeng; Zhongyi Dong; Dehua Wu; Li Liu
Journal:  J Transl Med       Date:  2011-06-25       Impact factor: 5.531

4.  Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

Authors:  Romain Drissi; Marie-Line Dubois; Mélanie Douziech; François-Michel Boisvert
Journal:  Mol Cell Proteomics       Date:  2015-05-11       Impact factor: 5.911

5.  Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Authors:  Zannel Blanchard; Nicole Mullins; Pavani Ellipeddi; Janice M Lage; Shawn McKinney; Rana El-Etriby; Xu Zhang; Raphael Isokpehi; Brenda Hernandez; Wael M Elshamy
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

6.  Inhibition of casein kinase 2 blocks G2/M transition in early embryo mitosis but not in oocyte meiosis in mouse.

Authors:  Fei Lin; Shi-Bing Cao; Xue-Shan Ma; Hai-Xiang Sun
Journal:  J Reprod Dev       Date:  2017-03-26       Impact factor: 2.214

7.  Cell cycle-dependent subcellular translocation of the human DNA licensing inhibitor geminin.

Authors:  Maria Dimaki; Georgia Xouri; Ioanna-Eleni Symeonidou; Chaido Sirinian; Hideo Nishitani; Stavros Taraviras; Zoi Lygerou
Journal:  J Biol Chem       Date:  2013-06-29       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.